EcoDrugPlus

Monoglyceride Lipase

Ensembl ID : ENSACIG00000017299
Gene Symbol: MGLL
1 Cross references
208 Possible Orthologues:

Motilin Receptor

Ensembl ID : ENSACIG00000023879
Gene Symbol: MLNR
1 Cross references
172 Possible Orthologues:

Natriuretic Peptide Receptor 1a

Ensembl ID : ENSACIG00000007049
Gene Symbol: NPR1A
1 Cross references
194 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSACIG00000006593
Gene Symbol: NPR3
1 Cross references
209 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSACIG00000022567
Gene Symbol: NPY2R
1 Cross references
183 Possible Orthologues:

Neuropeptide Y Receptor Y2, Like

Ensembl ID : ENSACIG00000014484
Gene Symbol: NPY2RL
1 Cross references
176 Possible Orthologues:

Neuropeptide Y Receptor Y4

Ensembl ID : ENSACIG00000017147
Gene Symbol: NPY4R
1 Cross references
137 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSACIG00000011689
Gene Symbol: NTSR1
1 Cross references
199 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSACIG00000005047
Gene Symbol: NTRK2
1 Cross references
209 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSACIG00000007582
Gene Symbol: NTRK3
1 Cross references
203 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSACIG00000016580
Gene Symbol: NTRK3
1 Cross references
183 Possible Orthologues:

Neurotrophic Tyrosine Kinase, Receptor, Type 1

Ensembl ID : ENSACIG00000001254
Gene Symbol: NTRK1
1 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).